Skip to content
← Langerhans Cell Histiocytosis

FOR PATIENTS · SOURCE READING

Immunotherapy

Source: Langerhans Cell Histiocytosis Treatment (PDQ®)–Patient Version, National Cancer Institute.

Source updated: June 6, 2024 · Captured 2026-09-09.

Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.

Context: Treatment Option Overview for LCH / Nine types of standard treatment are used to treat LCH.

Immunotherapy is a treatment that uses the patient’s immune system to fight cancer. Substances made by the body or made in a laboratory are used to boost, direct, or restore the body’s natural defenses against cancer. Thalidomide is a type of immunotherapy used to treat LCH.

Source links and citations

Preserved source evidence · Independent clinical review pending · Not medical advice